201609-38-3

Basic information

• Product Name: 4-METHOXY-4-PHENYLPIPERIDINE
• Synonyms: 4-METHOXY-4-PHENYLPIPERIDINE
• CAS NO: 201609-38-3
• Molecular Formula: C₁₂H₁₇NO
• Molecular Weight: 191.26948
• Mol File: 201609-38-3.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-METHOXY-4-PHENYLPIPERIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-METHOXY-4-PHENYLPIPERIDINE(201609-38-3)
• EPA Substance Registry System: 4-METHOXY-4-PHENYLPIPERIDINE(201609-38-3)

Safety Data

• Hazardous Substances Data: 201609-38-3(Hazardous Substances Data)

Upstream product

• 40807-61-2 4-hydroxy-4-phenylpiperidin 
• 172734-33-7 4-hydroxy-4-phenylpiperidine-1-carboxylic acid tert-butyl ester 
• 201609-37-2 4-methoxy-4-phenylpiperidine-1-carboxylic acid tert-butyl ester 

Downstream Products

• 201608-95-9 2a-[4-(4-methoxy-4-phenyl-piperidyl)butyl]-2a,3,4,5-tetrahydrobenz[cd]indole-2(1H)-one 

Relevant articles and documents

Propafenone analogue with additional H-bond acceptor group shows increased inhibitory activity on P-glycoprotein

P-glycoprotein (P-gp) is an ATP-dependent efflux pump that has a marked impact on the absorption, distribution, and excretion of therapeutic drugs. As P-gp inhibition can result in drug–drug interactions and altered drug bioavailability, identifying molec

Cyclic hexapeptides having antibiotic activity

This invention relates to new polypeptide compound represented by general formula (I), wherein R1, R2, R3, R4, R5 and R6 are as defined in the description or a salt thereof which has antimicrobial activities (especially, antifungal activities), inhibitory activity on β-1,3-glucan synthase, to process for preparation thereof, to a pharmaceutical composition comprising the same, and to a method for prophylactic and/or therapeutic treatment of infectious diseases including Pneumocystis carinii infection (e.g. Pneumocystis carinii pneumonia) in a human being or an animal.